학술논문
Safety and Activity of Flotetuzumab in Pediatric and Young Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia: Results from the COG PEPN1812 Phase 1 Trial
Document Type
Abstract
Author
Source
In Blood 15 November 2022 140 Supplement 1:6209-6210
Subject
Language
ISSN
0006-4971